Author: Sean Williams, The Motley Fool

The rewriting of several major index inclusion criteria has set retail investors up to be fleeced.

The company isn’t close to being profitable, yet it profiles as possibly the most expensive megacap stock on Wall Street.

A 10% drawdown in Wall Street’s iconic stock index means that bargains abound for patient investors.

It’s valuation is more attractive than it’s ever been.

These brand-name companies with high-octane dividend yields can pad the pocketbooks of patient investors.